Breast Cancer

Article	Citations
The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status	109
Prognostic significance and targeting tumor-associated macrophages in cancer: new insights and future perspectives	64
A machine learning-based radiomics model for the prediction of axillary lymph-node metastasis in breast cancer	55
Impact of exercise interventions on physical fitness in breast cancer patients and survivors: a systematic review	40
Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer	35
Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer	35
Friend or foe: ABCG2, ABCC1 and ABCB1 expression in triple-negative breast cancer	35
Effects of yoga on improving quality of life in patients with breast cancer: a meta-analysis of randomized controlled trials	34
Axillary surgery for breast cancer: past, present, and future	32
Inhibition of Cdc20 suppresses the metastasis in triple negative breast cancer (TNBC)	31
Associations of adiposity and weight change with recurrence and survival in breast cancer patients: a systematic review and meta-analysis	31
Human umbilical cord mesenchymal stem cell-derived exosomes inhibit migration and invasion of breast cancer cells via miR-21-5p/ZNF367 pathway	29
A systematic review of behaviour change techniques used in interventions to increase physical activity among breast cancer survivors	27
Overexpression of SERPINA3 promotes tumor invasion and migration, epithelial-mesenchymal-transition in triple-negative breast cancer cells	26
Immune-related biomarkers in triple-negative breast cancer	25
CD1a- and CD83-positive dendritic cells as prognostic markers of metastasis development in early breast cancer patients	24
Effect of Apatinib plus melatonin on vasculogenic mimicry formation by cancer stem cells from breast cancer cell line	23
Negative impact of the COVID-19 state of emergency on breast cancer screening participation in Japan	22
Overall assessment system of combined mammography and ultrasound for breast cancer screening in Japan	22
Impact of body mass index on pathological complete response following neoadjuvant chemotherapy in operable breast cancer: a meta-analysis	21
PI3K/AKT and MAPK1 molecular changes preceding matrix metallopeptidases overexpression during tamoxifen-resistance development are correlated to poor prognosis in breast cancer patients	19
The potential role of nicotine in breast cancer initiation, development, angiogenesis, invasion, metastasis, and resistance to therapy	19
Characteristics of female breast cancer in japan: annual report of the National Clinical Database in 2018	18
Discriminating low-grade ductal carcinoma in situ (DCIS) from non-low-grade DCIS or DCIS upgraded to invasive carcinoma: effective texture features on ultrafast dynamic contrast-enhanced magnetic reso	17
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition	16

Loco-regional therapy and the risk of breast cancer-related lymphedema: a systematic review and meta-analysis	16
Impact of artificial intelligence in breast cancer screening with mammography	16
Racial and socioeconomic inequities in breast cancer screening before and during the COVID-19 pandemic: analysis of two cohorts of women 50 years +	15
Identification of key tumor stroma-associated transcriptional signatures correlated with survival prognosis and tumor progression in breast cancer	15
Effects of a personal trainer-led exercise intervention on physical activity, physical function, and quality of life of breast cancer survivors	15
Japanese subgroup analysis of the phase 3 MONARCH 3 study of abemaciclib as initial therapy for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced brea	15
Obesity-related protein biomarkers for predicting breast cancer risk: an overview of systematic reviews	15
Japanese subpopulation analysis of MONARCH 2: phase 3 study of abemaciclib plus fulvestrant for treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer	14
Association between dietary phytochemical index and breast cancer: a case–control study	14
Microsurgical techniques in the treatment of breast cancer-related lymphedema: a systematic review of efficacy and patient outcomes	14
Quercetin: a silent retarder of fatty acid oxidation in breast cancer metastasis through steering of mitochondrial CPT1	13
LncRNA SNHG5 promotes the glycolysis and proliferation of breast cancer cell through regulating BACH1 via targeting miR-299	13
Characteristics of interstitial lung disease in patients from post-marketing data on metastatic breast cancer patients who received abemaciclib in Japan	12
Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospect	12
Isoforms of IDH in breast carcinoma: IDH2 as a potent prognostic factor associated with proliferation in estrogen-receptor positive cases	11
Podoplanin expression in cancer-associated fibroblasts predicts unfavorable prognosis in node-negative breast cancer patients with hormone receptor-positive/HER2 − negative subtype	11
Clinical effects of assessing electronic patient-reported outcomes monitoring symptomatic toxicities during breast cancer therapy: a nationwide and population-based study	11
The transverse musculocutaneous gracilis flap for autologous breast reconstruction: focus on donor site morbidity	11
Long-term outcomes of oligometastatic breast cancer patients treated with curative intent: an updated report	10
The safety of performing breast reconstruction during the COVID-19 pandemic	10
Nationwide mammographic screening and breast cancer mortality in Taiwan: an interrupted time-series analysis	10
Impact of obesity on clinical outcomes in hormone receptor-positive breast cancer: a systematic review	10
Clinicopathological characteristics, practical treatments, prognosis, and clinical issues of older breast cancer patients in Japan	10
Sexuality in breast cancer survivors: sexual experiences, emotions, and cognitions in a group of women under hormonal therapy	10
Accuracy of morphologic change measurements by ultrasound in predicting pathological response to neoadjuvant chemotherapy in triple-negative and HER2-positive breast cancer	10
Clinicopathological features of male patients with breast cancer based on a nationwide registry database in Japan	9
Alteration of Trop-2 expression in breast cancer cells by clinically used therapeutic agents and acquired tamoxifen resistance	9
Surgical treatment trends and identification of primary breast tumors after surgery in occult breast cancer: a study based on the Japanese National Clinical Database—Breast Cancer Registry	9
HER2-low-positive and response to NACT and prognosis in HER2-negative non-metastatic BC	9
Prognostic model based on six PD-1 expression and immune infiltration-associated genes predicts survival in breast cancer	9
Initial experience with targeted axillary dissection after neoadjuvant therapy in breast cancer patients	9
The associations of healthy lifestyle index with breast cancer incidence and mortality in a population-based study	9
Perceived physical fatigability improves after an exercise intervention among breast cancer survivors: a randomized clinical trial	9
Clinical benefit of treatment after trastuzumab emtansine for HER2-positive metastatic breast cancer: a real-world multi-centre cohort study in Japan (WJOG12519B)	9
Psychometric properties of the SF-6Dv2 in an Iranian breast cancer population	8
Sensitivity and specificity of screening mammography without clinical breast examination among Japanese women aged 40–49 years: analysis of data from the J-START results	8
Indices of peripheral leukocytes predict longer overall survival in breast cancer patients on eribulin in Japan	8
Discovery and function exploration of microRNA-155 as a molecular biomarker for early detection of breast cancer	8
Use and impact of breast cancer survivorship care plans: a systematic review	8
Association of lymphatic flow velocity with surgical outcomes in patients undergoing lymphovenous anastomosis for breast cancer-related lymphedema	8
TP53 signature diagnostic system using multiplex reverse transcription–polymerase chain reaction system enables prediction of prognosis of breast cancer patients	8
Breast-conserving therapy for breast cancer with BRCA mutations: a meta-analysis	8
Optimal duration of endocrine therapy with extended aromatase inhibitors for postmenopausal patients with hormone receptor-positive breast cancer: a meta-analysis	8
LncRNA FOXD3-AS1 promotes breast cancer progression by mediating ARF6	8
Diagnostic performance of dedicated breast positron emission tomography	8
Subcellular localization of EZH2 phosphorylated at T367 stratifies metaplastic breast carcinoma subtypes	8
PAM50- and immunohistochemistry-based subtypes of breast cancer and their relationship with breast cancer mortality in a population-based study	8
Assessment of integrative non-pharmacological interventions and quality of life in breast cancer patients using real-world data	8
Dynamic changes in quality of life, psychological status, and body image in women who underwent a mastectomy as compared with breast reconstruction: an 8-year follow up	7
Differential expression of the BCAT isoforms between breast cancer subtypes	7

PIK3CA somatic alterations in invasive breast cancers: different spectrum from Caucasians to Chinese detected by next generation sequencing	7
A transposon screen identifies enhancement of NF-κB pathway as a mechanism of resistance to eribulin	7
A history of severe nausea and vomiting during pregnancy predicts a higher incidence of postoperative nausea and vomiting after breast cancer surgery without breast reconstruction	7
Internal mammary lymph node metastasis in breast cancer patients based on anatomical imaging and functional imaging	7
Understanding breast cancer heterogeneity through non-genetic heterogeneity	7
A novel immune-related prognostic index for predicting breast cancer overall survival	7
Effect of patient decision aids on decisional conflict and regret associated with breast cancer surgery: a randomized controlled trial	7
The effectiveness of moisturizer on acute radiation-induced dermatitis in breast cancer patients: a systematic review and meta-analysis	7
Rethinking screening mammography in Japan: next-generation breast cancer screening through breast awareness and supplemental ultrasonography	6
Physicians’ perception about the impact of breast reconstruction on patient prognosis: a survey in Japan	6
Adenosquamous carcinoma of the breast: a population-based study	6
The effects of home-based exercise therapy for breast cancer-related fatigue induced by radical radiotherapy	6
High chromosome instability identified by low-pass whole-genome sequencing assay is associated with TP53 copy loss and worse prognosis in BRCA1 germline mutation breast cancer	6
Comparison of thoracic and abdominal deep inspiration breath holds in whole-breast irradiation for patients with left-sided breast cancer	6
ER–/PR+ breast cancer is controlled more effectively with an inflammatory inhibitor than hormonal inhibitor	6
Can breast MRI and adjunctive Doppler ultrasound improve the accuracy of predicting pathological complete response after neoadjuvant chemotherapy?	6
Interactions between exposure to polycyclic aromatic hydrocarbons and xenobiotic metabolism genes, and risk of breast cancer	6
Usefulness of new shear wave elastography in early predicting the efficacy of neoadjuvant chemotherapy for patients with breast cancer: where and when to measure is optimal?	6
Trends in adjuvant therapy after breast-conserving surgery for ductal carcinoma in situ of breast: a retrospective cohort study using the National Breast Cancer Registry of Japan	6
Genitourinary symptoms in women with breast cancer: what do oncology health professionals think and do about them?	6
Role of dietary fat on obesity-related postmenopausal breast cancer: insights from mouse models and methodological considerations	6
Breast implant associated anaplastic large cell lymphoma (BIA-ALCL): a challenging cytological diagnosis with hybrid PET/MRI staging and follow-up	6
Effect of radiotherapy after breast-conserving surgery in elderly patients with early breast cancer according to the AJCC 8th Edition Breast Cancer Staging System in Japan	6
BAHD1 serves as a critical regulator of breast cancer cell proliferation and invasion	6
Impact of background parenchymal enhancement levels on the diagnosis of contrast-enhanced digital mammography in evaluations of breast cancer: comparison with contrast-enhanced breast MRI	5
Breast cancer-derived exosomal lncRNA SNHG14 induces normal fibroblast activation to cancer-associated fibroblasts via the EBF1/FAM171A1 axis	5
Meta-analysis of nanoparticle albumin-bound paclitaxel used as neoadjuvant chemotherapy for operable breast cancer based on individual patient data (JBCRG-S01 study)	5
A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using multicatheter interstitial brachytherapy: clinical results with a median follow-up of 60 mo	5
The involvement of axillary reverse mapping nodes in patients with clinically node-negative breast cancer	5
Phytochemical-conjugated bio-safe gold nanoparticles in breast cancer: a comprehensive update	5
A risk scoring system based on tumor microenvironment cells to predict prognosis and immune activity in triple-negative breast cancer	5
Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™–HER2-FISH workflow	5
Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3	5
Evaluation of the ability of the Clinical Treatment Score at 5 years (CTS5) compared to other risk stratification methods to predict the response to an extended endocrine therapy in breast cancer pati	5
Recommendations for the management of breast cancer patients during the COVID-19 pandemic from the Japan Breast Cancer Society	5
Is adjuvant chemotherapy necessary in older patients with breast cancer?	5
Racial differences in predictive value of the 21-gene recurrence score assay: a population-based study using the SEER database	5
Interleukin (IL)-17A in triple-negative breast cancer: a potent prognostic factor associated with intratumoral neutrophil infiltration	5
Clinical outcomes and patient satisfaction with the use of biological and synthetic meshes in one-stage implant-based breast reconstruction	5
Relationship between MRI findings and invasive breast cancer with podoplanin-positive cancer-associated fibroblasts	5
Breast cancer screening using digital breast tomosynthesis compared to digital mammography alone for Japanese women	5
PI3K/AKT/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancer	5
Features from MRI texture analysis associated with survival outcomes in triple-negative breast cancer patients	5
Breast cancer patient-reported outcome of factors influencing cosmetic satisfaction after breast-conserving therapy	5
Dynamic tumor microenvironment, molecular heterogeneity, and distinct immunologic portrait of triple-negative breast cancer: an impact on classification and treatment approaches	5
Impact of serum vitamin D on the response and prognosis in breast cancer patients treated with neoadjuvant chemotherapy	5
Genetic medicine is accelerating in Japan	5
Conservative axillary surgery is emerging in the surgical management of breast cancer	5
Predictors of persistent post-surgical pain intensity and interference at 1 year after breast cancer surgery: assessing central sensitization, central sensitivity symptoms, and psychological factors	5
Incidence of and risk factors for non-hematologic toxicity with combined radiotherapy and CDK4/6 inhibitors in metastatic breast cancer using dose-volume parameters analysis: a multicenter cohort stud	4
Gene expression profile of normal breast tissue and body mass index	4
Predictive and prognostic significance of BRCAness in HER2-negative breast cancer	4
Impact of community-based exercise on fatigue in early breast cancer survivors: identifying potential determinants of change	4
Prognosis difference between HER2-low and HER2-zero breast cancer patients: a systematic review and meta-analysis	4
Evaluation of quality of life in breast cancer patients who underwent breast-conserving surgery or mastectomy using real-world data	4
Dietary intake of branched-chain amino acids in relation to the risk of breast cancer	4
Pathologic complete response and survival in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy	4
Identifying women with increased risk of breast cancer and implementing risk-reducing strategies and supplemental imaging	4
Quality of life improvement in breast cancer survivors affected by upper limb lymphedema through a novel multiperspective physical activity methodology: a monocentric pilot study	4
Characteristics, treatment trends, and long-term outcomes of Japanese patients with pregnancy-associated breast cancer (PABC)	4
Comprehensive analysis of DRAIC and TP53TG1 in breast cancer luminal subtypes through the construction of lncRNAs regulatory model	4
Efficacy and safety of talazoparib in Japanese patients with germline BRCA-mutated locally advanced or metastatic breast cancer: results of the phase 1 dose-expansion study	4
The association between physical health-related quality of life, physical functioning, and risk of contralateral breast cancer among older women	4
The value of prognostic ultrasound features of breast cancer in different molecular subtypes with a focus on triple negative disease	4
Predictors of invasive disease in patients preoperatively diagnosed with ductal carcinoma without stromal invasion, with breast magnetic resonance imaging (MRI) and ultrasound (US)	4
An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast canc	4
Is mastectomy with immediate reconstruction safe for patients undergoing neoadjuvant chemotherapy? A nationwide study from Korean Breast Cancer Society	4
miR-145, miR-205 and miR-451: potential tumor suppressors involved in the progression of in situ to invasive carcinoma of the breast	4
Average lifespan shortened due to breast cancer in Australia, 1990–2015	4
The Japanese Breast Cancer Society clinical practice guidelines for epidemiology and prevention of breast cancer, 2022 edition	4
Breast cancer preoperative 18FDG-PET, overall survival prognostic separation compared with the lymph node ratio	4
Sacituzumab govitecan in metastatic triple-negative breast cancer patients treated at Institut Curie Hospitals: efficacy, safety, and impact of brain metastases	4
Systematic review of synchronous contralateral axillary metastases in breast cancer: really M1 disease?	4
The feasibility of pelvic floor training to treat urinary incontinence in women with breast cancer: a telehealth intervention trial	4
Serotonin 5-HT7 receptor is a biomarker poor prognostic factor and induces proliferation of triple-negative breast cancer cells through FOXM1	4
Identification of prognostic genes signature and construction of ceRNA network in pirarubicin treatment of triple-negative breast cancer	4
Risk factors for arm lymphedema following breast cancer surgery: a Japanese nationwide database study of 84,022 patients	4
Effects of exercise on cancer-related cognitive impairment in breast cancer survivors: a scoping review	4
Quality of life and satisfaction of patients after oncoplastic or traditional breast-conserving surgery using the BREAST-Q (BCT module): a prospective study	3
Risk factors associated with chronic pain after mastectomy: a prospective study with a 5-year follow-up in Japan	3

New variant of breast-invasive lobular carcinoma with solid and encapsulated papillary carcinoma growth pattern	3
Association between mammographic breast composition and breast cancer risk among Japanese women: a retrospective cohort study	3
Predictive factors for response to neoadjuvant chemotherapy: inflammatory and immune markers in triple-negative breast cancer	3
Single-cell profile of tumor and immune cells in primary breast cancer, sentinel lymph node, and metastatic lymph node	3
Community-based outpatient rehabilitation for the treatment of breast cancer-related upper extremity disability: an evaluation of practice-based evidence	3
Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trial	3
SLC38A5 promotes glutamine metabolism and inhibits cisplatin chemosensitivity in breast cancer	3
MicroRNAs mediated interaction of tumor microenvironment cells with breast cancer cells during bone metastasis	3
Development and implementation of a decision aid for post-mastectomy breast reconstruction for Japanese women with breast cancer: a field-testing study	3
Pre-pectoral breast reconstruction: early and long-term safety evaluation of 146 unselected cases of the early pre-pectoral era of a single-institution, including cases with previous breast irradiatio	3
Performance analysis of screening mammography in Asian women under 40 years	3
Increased breast cancer mortality due to treatment delay and needle biopsy type: a retrospective analysis of SEER-medicare	3
Effects of gadobutrol on background parenchymal enhancement and differential diagnosis between benign and malignant lesions in dynamic magnetic resonance imaging of the breast	3
Venous thromboembolism in Japanese patients with breast cancer: subgroup analysis of the Cancer-VTE Registry	3
Radiation-induced angiosarcoma of the breast: retrospective analysis at a regional treatment centre	3
Predictive factors for patients who need treatment for chronic post-surgical pain (CPSP) after breast cancer surgery	3
Oncoplastic versus conventional breast-conserving surgery in breast cancer: a pooled analysis of 6941 female patients	3
FE65 in breast cancer and its clinicopathological significance	3
BAP1-defficient breast cancer in a patient with BAP1 cancer syndrome	3
A machine learning model based on readers’ characteristics to predict their performances in reading screening mammograms	3
Clinicopathologic and genetic features of metaplastic breast cancer with osseous differentiation: a series of 6 cases	3
Pilot trial of an electronic patient-reported outcome monitoring system in patients with metastatic breast cancer undergoing chemotherapy	3
Analysis of plasma HER2 copy number in cell-free DNA of breast cancer patients: a comparison with HER2 extracellular domain protein level in serum	3
Sentinel lymph node mapping in breast cancer patients following neoadjuvant chemotherapy: systematic review and meta-analysis about head to head comparison of cN0 and cN + patients	3
A follow-up study of a randomized controlled study evaluating safety and efficacy of leuprorelin acetate every-3-month depot for 2 versus 3 or more years with tamoxifen for 5 years as adjuvant treatme	3
Severity and risk factors of interval breast cancer in Queensland, Australia: a population-based study	3
Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within breast cancer subtypes and stages among older women: a SEER-Medicare analysis	3
Sarcopenia detected with bioelectrical impedance versus CT scan and chemotherapy tolerance in patients with early breast cancer	3
Neurospora crassa is a potential source of anti-cancer agents against breast cancer	3
The effect of combined risk factors on breast cancer-related lymphedema: a study using decision trees	3
Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cyt	3
What do we know about treating breast-cancer-related lymphedema? Review of the current knowledge about therapeutic options	3
The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition	2
Risk of primary lung cancer after breast cancer radiotherapy: a systematic review and meta-analysis	2
STK11 loss drives rapid progression in a breast cancer patient resulting in pulmonary tumor thrombotic microangiopathy	2
Relationships of physical and breast cancer phenotypes with three single-nucleotide polymorphisms (rs2046210, rs3757318, and rs3803662) associated with breast cancer risk in Japanese women	2
Consumption of dairy products and odds of breast cancer: an Iranian case–control study	2
What affects women’s decision-making on breast reconstruction after mastectomy for breast cancer?	2
Liquid biopsy for breast cancer and other solid tumors: a review of recent advances	2
Breast cancer screening guidelines: discrepancies raise concerns about validity	2
Comparison of short-term outcomes between pedicled- and free-flap autologous breast reconstruction: a nationwide inpatient database study in Japan	2
Efficacy and safety of surgical energy devices for axillary node dissection: a systematic review and network meta-analysis	2
A novel ADC targeting cell surface fibromodulin in a mouse model of triple-negative breast cancer	2
Antibiotic prophylaxis in breast surgery: a meta-analysis to identify the optimal strategy to reduce infection rates in breast surgery	2
Significance of prostate/pancreatic/skin cancer family history for detecting BRCA2 pathogenic variant careers among patients with breast cancer	2
Impact of neoadjuvant chemotherapy on the safety and long-term outcomes of patients undergoing immediate breast reconstruction after mastectomy	2
The hub ten gene-based risk score system using RNA m6A methylation regulator features and tumor immune microenvironment in breast cancer	2
KLF11 is an independent negative prognostic factor for breast cancer from a cohort study and induces proliferation and inhibits apoptosis in vitro	2
Options of locoregional therapy for primary foci of breast cancer influence the rate of nonregional lymph node metastasis in N2–N3 status patients: a SEER database analysis	2
Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines, 2018 edition: the tool for shared decision making between doctor and patient	2
CD68 and CD83 immune populations in non-metastatic axillary lymph nodes are of prognostic value for the survival and relapse of breast cancer patients	2
Radiation-induced angiosarcoma of the breast: individual participant meta-analysis of Japanese population	2
Patterns of treatment and their outcomes in primary breast lymphoma; a comprehensive population-based analysis	2
Prognosis of isolated locoregional recurrence after early breast cancer with immediate breast reconstruction surgery: a retrospective multi‑institutional study	2
The collagenase of the bacterium Clostridium histolyticum does not favor metastasis of breast cancer	2
Interstitial lung disorders following postoperative radiotherapy with concurrent or sequential hormonal therapy for breast cancer: a nationwide database study in Japan	2
Association of psychological distress with arm morbidity symptoms in breast cancer survivors: outcomes from the use of PHQ-9 and GAD-7 questionnaires	2
The Japanese breast cancer society clinical practice guidelines for pathological diagnosis of breast cancer, 2022 edition	2
Artificial intelligence computer-aided detection enhances synthesized mammograms: comparison with original digital mammograms alone and in combination with tomosynthesis images in an experimental sett	2
Multi-time scale transcriptomic analysis on the dynamic process of tamoxifen resistance development in breast cancer cell lines	2
Histological spatial analysis on the induction of PD-L1+ macrophages by CD8+ T cells at the marginal microenvironment of triple-negative breast cancer	2
Dynamic network biomarker to determine the critical point of breast cancer stage progression	2
Molecular targeted drugs resistance impairs double-strand break repair and sensitizes ER-positive breast cancer to PARP inhibitors	2
The Japanese Breast Cancer Society Clinical Practice Guidelines for surgical treatment of breast cancer, 2022 edition	2
CDC42 as an epigenetic regulator of ID4 in triple-negative breast tumors	2
Biology of primary breast cancer in older women beyond routine biomarkers	2
Hepatitis C virus may accelerate breast cancer progression by increasing mutant p53 and c-Myc oncoproteins circulating levels	2
Development and validation of a symptom illustration scale from the patient-reported outcome common terminology criteria for adverse events for patients with breast cancer	2
Impact of adjuvant endocrine therapy on prognosis in small hormone receptor-positive, HER2-negative early breast cancer	2
Practical approach to prevent COVID-19 infection at breast cancer screening	2
Returning individual genomic results to population-based cohort study participants with BRCA1/2 pathogenic variants	2
Does breast-conserving surgery with radiotherapy in BRCA-mutation carriers significantly increase ipsilateral breast tumor recurrence? A systematic review and meta-analysis	2
Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1)	2
Establishment of a N1-methyladenosine-related risk signature for breast carcinoma by bioinformatics analysis and experimental validation	2
Axillary dissection versus axillary observation for low risk, clinically node-negative invasive breast cancer: a systematic review and meta-analysis	2
Assessing the content based on ICF and quality based on COSMIN criteria of patient-reported outcome measures of functioning in breast cancer survivors: a systematic review	2
The transverse myocutaneous gracilis flap (TMG) for breast reconstruction: ipsi vs. contralateral harvest—aesthetic outcome and refinement procedures	2
Patient-reported outcomes of ductoscopy procedures for pathologic nipple discharge	2
Beneficial effects of transdermal administration of tamoxifen on capsular contracture after breast implantation in murine models	2
Effectiveness of eribulin as first-line or second-line chemotherapy for HER2-negative hormone-resistant advanced or metastatic breast cancer: findings from the multi-institutional, prospective, observ	2
Guideline-concordant treatment predicts survival: a National Cancer Database validation study of novel composite locoregional and systemic treatment scores among women with early stage breast cancer	2
The association of infectious mononucleosis and invasive breast cancer in The Health of Women (HOW) Study®	2
Role of circ-FOXO3 and miR-23a in radiosensitivity of breast cancer	2
Defer surgery in operable breast cancer: how long is too long?	2
Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR + , HER2- metastatic breast cancer patients in Japan	2
Deciphering the nexus between the tumor immune microenvironment and DNA methylation in subgrouping estrogen receptor-positive breast cancer	2
Phase 1 study of oral selective estrogen receptor degrader (SERD) amcenestrant (SAR439859), in Japanese women with ER-positive and HER2-negative advanced breast cancer (AMEERA-2)	2
Patient preferences for features of HER2-targeted treatment of advanced or metastatic breast cancer: a discrete-choice experiment study	2
Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer	2
Factors affecting prognosis in patients treated with bevacizumab plus paclitaxel as first-line chemotherapy for HER2-negative metastatic breast cancer: an international pooled analysis of individual p	2
High PPFIA1 expression promotes cancer survival by suppressing CD8+ T cells in breast cancer: drug discovery and machine learning approach	2
Mixed ductal–lobular carcinoma: an analysis of CDH1 DNA copy number variation and mutation	2